# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-038414
Filing Date
2023-11-13
Accepted
2023-11-13 07:57:15
Documents
51
Period of Report
2023-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | vyne-20230930.htm iXBRL | 10-Q | 827135
2 | EX-31.1 | vyne-20230930xexx311.htm | EX-31.1 | 9609
3 | EX-31.2 | vyne-20230930xexx312.htm | EX-31.2 | 9603
4 | EX-32.1 | vyne-20230930xexx321.htm | EX-32.1 | 5252
5 | EX-32.2 | vyne-20230930xexx322.htm | EX-32.2 | 5247
| Complete submission text file | 0001628280-23-038414.txt |  | 4341619

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | vyne-20230930.xsd | EX-101.SCH | 33131
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | vyne-20230930_cal.xml | EX-101.CAL | 48854
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | vyne-20230930_def.xml | EX-101.DEF | 180449
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | vyne-20230930_lab.xml | EX-101.LAB | 416140
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | vyne-20230930_pre.xml | EX-101.PRE | 283282
45 | EXTRACTED XBRL INSTANCE DOCUMENT | vyne-20230930_htm.xml | XML | 431858

Mailing Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

EIN.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38356 | Film No.: 231395189
SIC: 2834 Pharmaceutical Preparations